The influence of d-penicillamine on pulmonary fibrosis. Values are means (SD) if not indicated.
| Patients with d-Pen | Patients without d-Pen | p Value | |
|---|---|---|---|
| d-Pen, D-penicillamine; %VC, percentage vital capacity; %Tlco, percentage carbon monooxidase transfer factor; CT, computed tomograpy. | |||
| Changes in %VC levels | −2.19 (9.30) | −1.92 (9.13) | 0.45 |
| Changes in %Tlco levels | −7.38 (14.57) | −7.45 (14.66) | 0.51 |
| Patients with over 5% reduction of %VC levels (%) | 25.0 | 34.2 | 0.44 |
| Patients with over 5% reduction in %Tlco levels (%) | 57.1 | 57.1 | 1.00 |
| Patietns with progression of alveolitis or fibrosis in chest CT (%) | 15.4 | 20.8 | 0.69 |
| Patietns with progression of alveolitis or fibrosis in chest x ray (%) | 14.3 | 12.0 | 0.84 |